Media Highlights and Announcements
The West AustralianApril 22, 2022
A leading Perth cardiologist believes the recent spate of high-profile heart attacks should sound a warning about the increased health risks associated with modern living.
ArtryaApril 22, 2022
Ticker Insight News interviews John Barrington AM, on Artrya’s US expansion and the growing MedTech sector in Western Australia.
ProactiveApril 21, 2022
John Barrington discusses the company’s move into the US market, and its use of artificial intelligence in diagnosing early indicators for heart disease in clinical settings.
Medical Device News MagazineApril 20, 2022
Artrya Ltd announced the appointment of US Cardiologist Nicolas Chronos, MD, to its Clinical Advisory Board. He will promote key medical research partnerships and oversee US based research in support of Artrya’s US market entry.
Artrya’s CMO, Professor Girish Dwivedi, writes how CT scanning of the heart has changed how coronary artery disease can be assessed.
March 29, 2022
Artrya has opened a new US operation in Los Angeles. The company will market its AI-based solution, Artrya Salix, a device capable of analysing cardiac CT scans to illustrate a combination of coronary artery disease biomarkers.
Barron'sMarch 29, 2022
Australian medical technology company, today announces the formation of the Company’s American subsidiary, Artrya USA, Inc. (Artrya US)
The West AustralianMarch 29, 2022
Ted Schwab and Jory Tremblay have been appointed as co-CEOs of the company’s US subsidiary.
March 21, 2022
Artrya strategically partnered with digital product companies Hatchd and Adapptor to implement our Artrya Salix product vision.